Cevimeline Market

Global Cevimeline Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Jan, 2019 | Report ID: 58053 | 122 | Pharmaceuticals and Healthcare
Cevimeline (trade name Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. It is used in the treatment of dry mouth and especially associated with SjÁ¶gren's syndrome.


Scope of the Report:
The worldwide market for Cevimeline is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Cevimeline in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.


Market Segment by Manufacturers, this report covers
Daiichi Sankyo
Novel Laboratories
Rising Pharmaceuticals
West-Ward Pharmaceuticals
Lupin
Sun Pharmaceutical


Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


Market Segment by Type, covers
30mg Caplule
Type II


Market Segment by Applications, can be divided into
Hospital
Drug store



There are 15 Chapters to deeply display the global Cevimeline market.
Chapter 1, to describe Cevimeline Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cevimeline, with sales, revenue, and price of Cevimeline, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cevimeline, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cevimeline market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cevimeline sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



1 Market Overview

1.1 Cevimeline Introduction

1.2 Market Analysis by Type

1.2.1 30mg Caplule

1.2.2 Type II

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Drug store

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Daiichi Sankyo

2.1.1 Business Overview

2.1.2 Cevimeline Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Daiichi Sankyo Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novel Laboratories

2.2.1 Business Overview

2.2.2 Cevimeline Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novel Laboratories Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Rising Pharmaceuticals

2.3.1 Business Overview

2.3.2 Cevimeline Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Rising Pharmaceuticals Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 West-Ward Pharmaceuticals

2.4.1 Business Overview

2.4.2 Cevimeline Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 West-Ward Pharmaceuticals Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Lupin

2.5.1 Business Overview

2.5.2 Cevimeline Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Lupin Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sun Pharmaceutical

2.6.1 Business Overview

2.6.2 Cevimeline Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sun Pharmaceutical Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cevimeline Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cevimeline Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cevimeline Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cevimeline Manufacturer Market Share in 2017

3.3.2 Top 6 Cevimeline Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cevimeline Market Analysis by Regions

4.1 Global Cevimeline Sales, Revenue and Market Share by Regions

4.1.1 Global Cevimeline Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cevimeline Revenue and Market Share by Regions (2013-2018)

4.2 North America Cevimeline Sales and Growth Rate (2013-2018)

4.3 Europe Cevimeline Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cevimeline Sales and Growth Rate (2013-2018)

4.5 South America Cevimeline Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cevimeline Sales and Growth Rate (2013-2018)

5 North America Cevimeline by Countries

5.1 North America Cevimeline Sales, Revenue and Market Share by Countries

5.1.1 North America Cevimeline Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cevimeline Revenue and Market Share by Countries (2013-2018)

5.2 United States Cevimeline Sales and Growth Rate (2013-2018)

5.3 Canada Cevimeline Sales and Growth Rate (2013-2018)

5.4 Mexico Cevimeline Sales and Growth Rate (2013-2018)

6 Europe Cevimeline by Countries

6.1 Europe Cevimeline Sales, Revenue and Market Share by Countries

6.1.1 Europe Cevimeline Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cevimeline Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cevimeline Sales and Growth Rate (2013-2018)

6.3 UK Cevimeline Sales and Growth Rate (2013-2018)

6.4 France Cevimeline Sales and Growth Rate (2013-2018)

6.5 Russia Cevimeline Sales and Growth Rate (2013-2018)

6.6 Italy Cevimeline Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cevimeline by Countries

7.1 Asia-Pacific Cevimeline Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cevimeline Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cevimeline Revenue and Market Share by Countries (2013-2018)

7.2 China Cevimeline Sales and Growth Rate (2013-2018)

7.3 Japan Cevimeline Sales and Growth Rate (2013-2018)

7.4 Korea Cevimeline Sales and Growth Rate (2013-2018)

7.5 India Cevimeline Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cevimeline Sales and Growth Rate (2013-2018)

8 South America Cevimeline by Countries

8.1 South America Cevimeline Sales, Revenue and Market Share by Countries

8.1.1 South America Cevimeline Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cevimeline Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cevimeline Sales and Growth Rate (2013-2018)

8.3 Argentina Cevimeline Sales and Growth Rate (2013-2018)

8.4 Colombia Cevimeline Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cevimeline by Countries

9.1 Middle East and Africa Cevimeline Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cevimeline Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cevimeline Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cevimeline Sales and Growth Rate (2013-2018)

9.3 UAE Cevimeline Sales and Growth Rate (2013-2018)

9.4 Egypt Cevimeline Sales and Growth Rate (2013-2018)

9.5 Nigeria Cevimeline Sales and Growth Rate (2013-2018)

9.6 South Africa Cevimeline Sales and Growth Rate (2013-2018)

10 Global Cevimeline Market Segment by Type

10.1 Global Cevimeline Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cevimeline Sales and Market Share by Type (2013-2018)

10.1.2 Global Cevimeline Revenue and Market Share by Type (2013-2018)

10.2 30mg Caplule Sales Growth and Price

10.2.1 Global 30mg Caplule Sales Growth (2013-2018)

10.2.2 Global 30mg Caplule Price (2013-2018)

10.3 Type II Sales Growth and Price

10.3.1 Global Type II Sales Growth (2013-2018)

10.3.2 Global Type II Price (2013-2018)

11 Global Cevimeline Market Segment by Application

11.1 Global Cevimeline Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Drug store Sales Growth (2013-2018)

12 Cevimeline Market Forecast (2018-2023)

12.1 Global Cevimeline Sales, Revenue and Growth Rate (2018-2023)

12.2 Cevimeline Market Forecast by Regions (2018-2023)

12.2.1 North America Cevimeline Market Forecast (2018-2023)

12.2.2 Europe Cevimeline Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cevimeline Market Forecast (2018-2023)

12.2.4 South America Cevimeline Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cevimeline Market Forecast (2018-2023)

12.3 Cevimeline Market Forecast by Type (2018-2023)

12.3.1 Global Cevimeline Sales Forecast by Type (2018-2023)

12.3.2 Global Cevimeline Market Share Forecast by Type (2018-2023)

12.4 Cevimeline Market Forecast by Application (2018-2023)

12.4.1 Global Cevimeline Sales Forecast by Application (2018-2023)

12.4.2 Global Cevimeline Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Cevimeline Picture

Table Product Specifications of Cevimeline

Figure Global Sales Market Share of Cevimeline by Types in 2017

Table Cevimeline Types for Major Manufacturers

Figure 30mg Caplule Picture

Figure Type II Picture

Figure Cevimeline Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Drug store Picture

Figure United States Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure France Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure UK Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure China Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure India Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Cevimeline Revenue (Value) and Growth Rate (2013-2023)

Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors

Table Daiichi Sankyo Cevimeline Type and Applications

Table Daiichi Sankyo Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novel Laboratories Basic Information, Manufacturing Base and Competitors

Table Novel Laboratories Cevimeline Type and Applications

Table Novel Laboratories Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Rising Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Rising Pharmaceuticals Cevimeline Type and Applications

Table Rising Pharmaceuticals Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table West-Ward Pharmaceuticals Cevimeline Type and Applications

Table West-Ward Pharmaceuticals Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Lupin Basic Information, Manufacturing Base and Competitors

Table Lupin Cevimeline Type and Applications

Table Lupin Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Sun Pharmaceutical Cevimeline Type and Applications

Table Sun Pharmaceutical Cevimeline Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Cevimeline Sales by Manufacturer (2016-2017)

Figure Global Cevimeline Sales Market Share by Manufacturer in 2016

Figure Global Cevimeline Sales Market Share by Manufacturer in 2017

Table Global Cevimeline Revenue by Manufacturer (2016-2017)

Figure Global Cevimeline Revenue Market Share by Manufacturer in 2016

Figure Global Cevimeline Revenue Market Share by Manufacturer in 2017

Figure Top 3 Cevimeline Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Cevimeline Manufacturer (Revenue) Market Share in 2017

Figure Global Cevimeline Sales and Growth Rate (2013-2018)

Figure Global Cevimeline Revenue and Growth Rate (2013-2018)

Table Global Cevimeline Sales by Regions (2013-2018)

Table Global Cevimeline Sales Market Share by Regions (2013-2018)

Table Global Cevimeline Revenue by Regions (2013-2018)

Figure Global Cevimeline Revenue Market Share by Regions in 2013

Figure Global Cevimeline Revenue Market Share by Regions in 2017

Figure North America Cevimeline Sales and Growth Rate (2013-2018)

Figure Europe Cevimeline Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Cevimeline Sales and Growth Rate (2013-2018)

Figure South America Cevimeline Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Cevimeline Sales and Growth Rate (2013-2018)

Figure North America Cevimeline Revenue and Growth Rate (2013-2018)

Table North America Cevimeline Sales by Countries (2013-2018)

Table North America Cevimeline Sales Market Share by Countries (2013-2018)

Figure North America Cevimeline Sales Market Share by Countries in 2013

Figure North America Cevimeline Sales Market Share by Countries in 2017

Table North America Cevimeline Revenue by Countries (2013-2018)

Table North America Cevimeline Revenue Market Share by Countries (2013-2018)

Figure North America Cevimeline Revenue Market Share by Countries in 2013

Figure North America Cevimeline Revenue Market Share by Countries in 2017

Figure United States Cevimeline Sales and Growth Rate (2013-2018)

Figure Canada Cevimeline Sales and Growth Rate (2013-2018)

Figure Mexico Cevimeline Sales and Growth Rate (2013-2018)

Figure Europe Cevimeline Revenue and Growth Rate (2013-2018)

Table Europe Cevimeline Sales by Countries (2013-2018)

Table Europe Cevimeline Sales Market Share by Countries (2013-2018)

Table Europe Cevimeline Revenue by Countries (2013-2018)

Figure Europe Cevimeline Revenue Market Share by Countries in 2016

Figure Europe Cevimeline Revenue Market Share by Countries in 2017

Figure Germany Cevimeline Sales and Growth Rate (2013-2018)

Figure UK Cevimeline Sales and Growth Rate (2013-2018)

Figure France Cevimeline Sales and Growth Rate (2013-2018)

Figure Russia Cevimeline Sales and Growth Rate (2013-2018)

Figure Italy Cevimeline Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Cevimeline Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Cevimeline Sales by Countries (2013-2018)

Table Asia-Pacific Cevimeline Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Cevimeline Sales Market Share by Countries 2017

Table Asia-Pacific Cevimeline Revenue by Countries (2013-2018)

Figure Asia-Pacific Cevimeline Revenue Market Share by Countries 2017

Figure China Cevimeline Sales and Growth Rate (2013-2018)

Figure Japan Cevimeline Sales and Growth Rate (2013-2018)

Figure Korea Cevimeline Sales and Growth Rate (2013-2018)

Figure India Cevimeline Sales and Growth Rate (2013-2018)

Figure Southeast Asia Cevimeline Sales and Growth Rate (2013-2018)

Figure South America Cevimeline Revenue and Growth Rate (2013-2018)

Table South America Cevimeline Sales by Countries (2013-2018)

Table South America Cevimeline Sales Market Share by Countries (2013-2018)

Figure South America Cevimeline Sales Market Share by Countries in 2017

Table South America Cevimeline Revenue by Countries (2013-2018)

Table South America Cevimeline Revenue Market Share by Countries (2013-2018)

Figure South America Cevimeline Revenue Market Share by Countries in 2017

Figure Brazil Cevimeline Sales and Growth Rate (2013-2018)

Figure Argentina Cevimeline Sales and Growth Rate (2013-2018)

Figure Colombia Cevimeline Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Cevimeline Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Cevimeline Sales by Countries (2013-2018)

Table Middle East and Africa Cevimeline Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Cevimeline Sales Market Share by Countries in 2017

Table Middle East and Africa Cevimeline Revenue by Countries (2013-2018)

Table Middle East and Africa Cevimeline Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cevimeline Revenue Market Share by Countries in 2013

Figure Middle East and Africa Cevimeline Revenue Market Share by Countries in 2017

Figure Saudi Arabia Cevimeline Sales and Growth Rate (2013-2018)

Figure UAE Cevimeline Sales and Growth Rate (2013-2018)

Figure Egypt Cevimeline Sales and Growth Rate (2013-2018)

Figure Nigeria Cevimeline Sales and Growth Rate (2013-2018)

Figure South Africa Cevimeline Sales and Growth Rate (2013-2018)

Table Global Cevimeline Sales by Type (2013-2018)

Table Global Cevimeline Sales Share by Type (2013-2018)

Table Global Cevimeline Revenue by Type (2013-2018)

Table Global Cevimeline Revenue Share by Type (2013-2018)

Figure Global 30mg Caplule Sales Growth (2013-2018)

Figure Global 30mg Caplule Price (2013-2018)

Figure Global Type II Sales Growth (2013-2018)

Figure Global Type II Price (2013-2018)

Table Global Cevimeline Sales by Application (2013-2018)

Table Global Cevimeline Sales Share by Application (2013-2018)

Figure Global Drug store Sales Growth (2013-2018)

Figure Global Cevimeline Sales, Revenue and Growth Rate (2018-2023)

Table Global Cevimeline Sales Forecast by Regions (2018-2023)

Table Global Cevimeline Market Share Forecast by Regions (2018-2023)

Figure North America Sales Cevimeline Market Forecast (2018-2023)

Figure Europe Sales Cevimeline Market Forecast (2018-2023)

Figure Asia-Pacific Sales Cevimeline Market Forecast (2018-2023)

Figure South America Sales Cevimeline Market Forecast (2018-2023)

Figure Middle East and Africa Sales Cevimeline Market Forecast (2018-2023)

Table Global Cevimeline Sales Forecast by Type (2018-2023)

Table Global Cevimeline Market Share Forecast by Type (2018-2023)

Table Global Cevimeline Sales Forecast by Application (2018-2023)

Table Global Cevimeline Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Sample Request is not available

Shop Now

Buy Now

Quick Contact

+1